ALA & EPA/DHA (w-3) Effects on Inflammatory Markers In Insulin Resistant Adults

The major purpose of this study is to examine the effect of two sources of dietary omega-3 fatty acids, each given at two doses, on potential health benefits related to cardiovascular disease prevention. The two sources of dietary omega-3 fatty acids will be fish oil, and flax seed oil.

Stanford is not currently accepting new patients for this trial. You may want to check clinicaltrials.gov to see if other locations are recruiting.

Investigator(s):

Intervention(s):

  • behavioral : Flax Seed Oil
  • behavioral : Fish Oil

Phase: Phase 2/Phase 3

Eligibility

Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

Gender: - Both women and men - Age: > or = 18 years - Ethnicity and race: All ethnic and racial backgrounds welcome - As defined in ATP III of the National Cholesterol Education program, the metabolic syndrome will be diagnosed as presence of at least three of the following, which will be measured at the screening clinic visit: Central obesity as measured by waist circumference: - Men: Greater than 40 inches - Women: Greater than 35 inches - Fasting blood triglycerides greater than or equal to 150 mg/dL - Blood HDL cholesterol: - Men: Less than 40 mg/dL - Women: Less than 50 mg/dL - Blood pressure greater than or equal to 130/85 mmHg - Fasting glucose greater than or equal to 100 mg/dL Planning to be available for clinic visits and bottle pick-ups for the 8 weeks of study participation Ability and willingness to give written informed consent No known active psychiatric illness.

External Links

Explore related trials

Contact information

Primary Contact:

Antonella Dewell 6507368577

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: